{"id":"NCT00858637","sponsor":"Mitsubishi Tanabe Pharma Corporation","briefTitle":"Efficacy and Safety Study of MCI-196 Versus Simvastatin for Dyslipidaemia in Chronic Kidney Disease (CKD) Subjects on Dialysis","officialTitle":"A Phase III, Multicentre, Double-blind, Double-dummy, Randomised, Flexible-dose, Comparative Study of MCI-196 Versus Simvastatin for the Treatment of Dyslipidaemia in Subjects With Chronic Kidney Disease on Dialysis (Incorporating a Placebo-controlled Withdrawal Phase)","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2009-03","primaryCompletion":"2010-03","completion":"2010-03","firstPosted":"2009-03-10","resultsPosted":"2014-10-17","lastUpdate":"2014-12-30"},"enrollment":260,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Chronic Kidney Disease"],"interventions":[{"type":"DRUG","name":"MCI-196","otherNames":["Colestilan(INN)","Colestimide(JAN)","CHOLEBINE®","BindRen®"]},{"type":"DRUG","name":"Placebo of Simvastatin","otherNames":[]},{"type":"DRUG","name":"Simvastatin","otherNames":[]},{"type":"DRUG","name":"Placebo of MCI-196","otherNames":[]}],"arms":[{"label":"1 MCI-196","type":"EXPERIMENTAL"},{"label":"2 Placebo of MCI-196","type":"PLACEBO_COMPARATOR"},{"label":"3 Simvastatin","type":"ACTIVE_COMPARATOR"},{"label":"4 Placebo of Simvastatin","type":"PLACEBO_COMPARATOR"}],"summary":"The primary objective of this study is to demonstrate the superiority of MCI-196 over placebo and non-inferiority with simvastatin in reducing serum low-density lipoprotein (LDL)-cholesterol in subjects with chronic kidney disease Stage V on dialysis. This study incorporates a Washout Period and two treatment periods - an active comparison phase and a placebo-controlled withdrawal phase.","primaryOutcome":{"measure":"Percent Change in Serum LDL-cholesterol Levels From Week 16 to Week 20 (LOCF) (ITT2)","timeFrame":"week20 minus week16","effectByArm":[{"arm":"MCI-196 (Active) + Simvastin (Placebo)/ Withdrawal Phase","deltaMin":4.03,"sd":19.92},{"arm":"MCI-196 (Placebo) + Simvastin (Placebo)/ Withdrawal Phase","deltaMin":42.55,"sd":30.96},{"arm":"Simvastin (Active) + MCI-196 (Placebo)/ Withdrawal Phase","deltaMin":2.76,"sd":18.43},{"arm":"Simvastin (Placebo) + MCI-196 (Placebo)/ Withdrawal Phase","deltaMin":49.84,"sd":41.89}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":5,"exclusionCount":12},"locations":{"siteCount":39,"countries":["Belarus","Bulgaria","Croatia","Denmark","Indonesia","Israel","Italy","Latvia","Lithuania","Malaysia","Romania","Singapore","Thailand"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":16,"n":128},"commonTop":["Anaemia","Nausea","Hypotension","Headache","Dyspepsia"]}}